Just did a quick conversion to extrapolate what these companies were valued at when the deals were made, and I must admit I have no idea how these companies compare/relate to RAC (but I have a fair idea wombat doesand this is why he listed them), but the deal values are between ~0.6 and $20 Billion. Even the smallest one is 2.5x RAC's current MC, and of course the deal itself then still sets the scene for a massive further growth (even if it's for 50% of the gain only).
% $M Equiv $M for 100% 1 Forty Seven 100% 4,900 4,900 2 Arcus 13% 375 2,885 3 Pionyr 50% 275 550 4 Tizona 50% 300 600 5 Tango 7% 145 2,071 6 Jounce 14% 120 857 7 Immunomedics 100% 21,000 21,000
Oncology - Pharma Deals News, page-89
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
0.020(1.31%) |
Mkt cap ! $260.7M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.60 | $1.53 | $78.30K | 50.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 493 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 2773 | 1 |
View Market Depth
| Last trade - 14.41pm 17/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |